In conversation with Beghou’s Marc Iskowitz, commercial operations leader Lori Nemyier shares what separates biotechs that merely reach launch from those that win at launch. Drawing on her experience advising emerging biotech and biopharma companies, she outlines four keys to a successful launch:
- Build the operating model early:Start 12–18 months pre-launch, not after marketing and market access strategies are already locked.
- Let business needs drive data purchases: Sequence data acquisition deliberately instead of buying reactively.
- Design for complexity in rare disease and CGT: Build operating models that reflect real-world patient journeys, not simplified defaults.
- Fix fragmentation before it slows you down: Unify data, systems, and workstreams so the whole organization operates from one version of the truth.
The piece argues that launch isn't the finish line — it's the beginning of execution, and commercial ops is what makes strategy real.